South San Francisco, CA, December 11, 2023 (Business Wire) -- Electra Therapeutics, Inc. has named Kathy Dong, PharmD, MBA, as President and CEO. Dr. Dong steps into this role as Electra sees positive clinical outcomes for its lead drug, ELA026, addressing the life-threatening inflammatory disease, secondary hemophagocytic lymphohistiocytosis (sHLH).
Read full article here.
NY, NY, April 18, 2024 (Business Wire) -- Metsera, Inc., a pioneering player in the clinical-stage biopharmaceutical realm focusing on innovative treatments for obesity and metabolic ailments, has e
Cambridge, MA, April 23 2024 (PRNewswire) -- Flare Therapeutics Inc. has undergone a notable leadership transition with the selection of Dr. Douglas Manion, M.D., FRCP (C), as its newly appointed Ch
Wilmington, DE, April 23, 2024 (RTTNews) -- Incyte Corp. (INCY) is buying Escient Pharmaceuticals and its assets for $750 million, plus any cash left over when the deal closes. This acquisition need
